Endothelial VEGFR2 insufficiency promotes the transition of lymphatic to hematopoietic transcriptional programs

Lv J et al (2023) Epigenetic landscape reveals MECOM as an endothelial lineage regulator. Nat Commun 14(1):2390

Article  PubMed  PubMed Central  Google Scholar 

Lee S et al (2009) Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate. Blood 113(8):1856–1859

Article  PubMed  Google Scholar 

Wigle JT et al (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21(7):1505–1513

Article  PubMed  PubMed Central  Google Scholar 

Hong YK et al (2002) Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 225(3):351–357

Article  PubMed  Google Scholar 

Srinivasan RS et al (2010) The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev 24(7):696–707

Article  PubMed  PubMed Central  Google Scholar 

Ma W et al (2021) Mitochondrial respiration controls the Prox1-Vegfr3 feedback loop during lymphatic endothelial cell fate specification and maintenance. Sci Adv 7(18):eabe7359

Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 438(7070):946–953

Article  PubMed  Google Scholar 

Petrova TV, Koh GY (2020) Biological functions of lymphatic vessels. Science 369(6500):eaax4063

Article  PubMed  Google Scholar 

Oliver G, Detmar M (2002) The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 16(7):773–783

Article  PubMed  Google Scholar 

Potente M, Makinen T (2017) Vascular heterogeneity and specialization in development and disease. Nat Rev Mol Cell Biol 18(8):477–494

Article  PubMed  Google Scholar 

Alitalo K (2011) The lymphatic vasculature in disease. Nat Med 17(11):1371–1380

Article  PubMed  Google Scholar 

Koch S et al (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437(2):169–183

Article  PubMed  Google Scholar 

Jeltsch M et al (2013) Receptor tyrosine kinase-mediated angiogenesis. Cold Spring Harb Perspect Biol 5(9):a009183

Article  PubMed  PubMed Central  Google Scholar 

Adams RH, Alitalo K (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8(6):464–478

Article  PubMed  Google Scholar 

Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9(6):669–676

Article  PubMed  Google Scholar 

Secker GA, Harvey NL (2021) Regulation of VEGFR signalling in lymphatic vascular development and disease: an update. Int J Mol Sci 22(14):7760

Article  PubMed  PubMed Central  Google Scholar 

Karaman S, Leppanen VM, Alitalo K (2018) Vascular endothelial growth factor signaling in development and disease. Development 145(14):dev151019

Article  PubMed  Google Scholar 

Karaman S et al (2022) Interplay of vascular endothelial growth factor receptors in organ-specific vessel maintenance. J Exp Med 219(3):e20210565

Article  PubMed  PubMed Central  Google Scholar 

Makinen T et al (2001) Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7(2):199–205

Article  PubMed  Google Scholar 

Karkkainen MJ et al (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5(1):74–80

Article  PubMed  Google Scholar 

Zhang L et al (2010) VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res 20(12):1319–1331

Article  PubMed  Google Scholar 

Zhang Y et al (2018) Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms. Nat Commun 9(1):1296

Article  PubMed  PubMed Central  Google Scholar 

Dixelius J et al (2003) Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J Biol Chem 278(42):40973–40979

Article  PubMed  Google Scholar 

Deng Y, Zhang X, Simons M (2015) Molecular controls of lymphatic VEGFR3 signaling. Arterioscler Thromb Vasc Biol 35(2):421–429

Article  PubMed  Google Scholar 

Nilsson I et al (2010) VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. Embo J 29(8):1377–1388

Article  PubMed  PubMed Central  Google Scholar 

Albuquerque RJ et al (2009) Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med 15(9):1023–1030

Article  PubMed  PubMed Central  Google Scholar 

Vogrin AJ et al (2019) Evolutionary differences in the Vegf/Vegfr code reveal organotypic roles for the endothelial cell receptor kdr in developmental lymphangiogenesis. Cell Rep 28(8):2023–2036 e4

Article  PubMed  Google Scholar 

Dellinger MT et al (2013) Vascular endothelial growth factor receptor-2 promotes the development of the lymphatic vasculature. PLoS ONE 8(9):e74686

Article  PubMed  PubMed Central  Google Scholar 

Nagy JA et al (2002) Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196(11):1497–1506

Article  PubMed  PubMed Central  Google Scholar 

Wirzenius M et al (2007) Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med 204(6):1431–1440

Article  PubMed  PubMed Central  Google Scholar 

Li X et al (2016) VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread. Nat Commun 7:11017

Article  PubMed  PubMed Central  Google Scholar 

Okabe K et al (2014) Neurons limit angiogenesis by titrating VEGF in Retina. Cell 159(3):584–596

Article  PubMed  Google Scholar 

Bazigou E et al (2011) Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J Clin Invest 121(8):2984–2992

Article  PubMed  PubMed Central  Google Scholar 

Kazenwadel J et al (2023) A Prox1 enhancer represses haematopoiesis in the lymphatic vasculature. Nature 614(7947):343–348

Article  PubMed  Google Scholar 

Haigh JJ et al (2003) Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. Dev Biol 262(2):225–241

Article  PubMed  Google Scholar 

Liu Q et al (2015) Genetic targeting of sprouting angiogenesis using Apln-CreER. Nat Commun 6:6020

Article  PubMed  PubMed Central  Google Scholar 

Choi I et al (2011) Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse. Blood 117(1):362–365

Article 

Comments (0)

No login
gif